Clinical Trials Logo

Ectopic Pregnancy clinical trials

View clinical trials related to Ectopic Pregnancy.

Filter by:

NCT ID: NCT06354439 Recruiting - Ectopic Pregnancy Clinical Trials

Use of Letrozole for Ectopic Pregnancy

EcZOL
Start date: March 27, 2024
Phase: Phase 4
Study type: Interventional

A randomized clinical trial using oral letrozole 10mg/day for 7 days, for treating early cases of ectopic pregnancy, compared to intramuscular methotrexate

NCT ID: NCT06300333 Not yet recruiting - Ectopic Pregnancy Clinical Trials

Treatment of Ectopic Pregnancy by Low Dose of Methotrexate

Start date: March 2024
Phase:
Study type: Observational

Evaluate the efficacy and safety of the use of low dose regimen of methotrexate in treatment of tubal undisturbed tubal ectopic pregnancy

NCT ID: NCT06165770 Not yet recruiting - Ectopic Pregnancy Clinical Trials

Cornual Pregnancy: Results of a Single-center Retrospective Experience and Systematic Review on Reproductive Outcomes

Start date: December 2023
Phase:
Study type: Observational

To present our experience in the diagnosis and management of cornual pregnancy. A systematic review was also conducted to investigate reproductive outcomes after treatment.

NCT ID: NCT05918718 Active, not recruiting - Ectopic Pregnancy Clinical Trials

Assessment of the Efficacy of Letrozole in the Treatment of Ectopic Pregnancy

Start date: January 20, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

In this study, about 150 women diagnosed with ectopic pregnancy who are referred to the Obstetrics and Gynecology Center of Valiasr Hospital are included in the study. Demographic information including both gynecological and obstetrical data is collected. Ectopic ectopic pregnancy is confirmed by transvaginal ultrasound. The patients are randomly allocated to three groups The first group will receive a single dose of methotrexate The second group will receive letrozole within a 10-day period, twice a day The third group will receive letrozole in a 5-day period three times a day In the first group, the first day of drug injection is counted, and the drug is measured at a dose of 50 mg/m2 and divided intramuscularly. The hcg level is measured on the first day, and the hcg serum level is routinely measured on the fourth, seventh and fourteenth day. In the second group, letrozole is given in the form of 2.5 mg tablets twice a day for 10 days. And on the fourth, seventh and fourteenth day, the HCG level is measured. In the third group, letrozole is given in the form of 2.5 mg tablets 3 times a day for 5 days, and hCG levels are measured on days 4, 7, and 14. Also, the level of blood cells, liver enzymes, urea level and serum creatinine level are measured on the first day and the seventh day after the treatment. The level of antimullerin hormone is measured on the first day and 3 months after the treatment.

NCT ID: NCT05890066 Not yet recruiting - Ectopic Pregnancy Clinical Trials

Single-port Versus Multi-port Laparoscopic Surgery for Ectopic Pregnancy

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

This study aims to compare the effectiveness and Safety of Single-port Versus Multi-port Laparoscopic Surgery in the Treatment of Ectopic Pregnancy

NCT ID: NCT05479786 Completed - Ectopic Pregnancy Clinical Trials

Reproductive Outcomes After a Previous Episode of Tubal Ectopic Pregnancy in Patients Managed Expectantly and Surgically

Start date: January 1, 2012
Phase:
Study type: Observational

Although ectopic pregnancy was considered a leading cause of first-trimester maternal mortalities, current technological improvements allowed early diagnosis and opened a door for applying less invasive approaches. A tubal pregnancy could be managed either expectantly, medically, or surgically. The expectant management of ectopic pregnancy relies on the fact that a considerable proportion of ectopic gestations terminate by spontaneous tubal abortion. This approach is usually kept for stable cases with a small gestational sac and low beta-human chorionic gonadotropin (beta-HCG) serum levels. For hemodynamically unstable patients, higher levels of beta-HCG, and larger gestational sacs, surgery is often considered as the treatment of choice (16). Considering this background, the study aims to analyze the subsequent natural reproductive outcomes of patients that had a previous tubal ectopic pregnancy and were managed either expectantly or surgically. Moreover, it amis to determine the factors that could influence the fertility potential of these patients in each treatment group.

NCT ID: NCT05446012 Completed - Thyroid Diseases Clinical Trials

Relationship Between Ectopic Pregnancy and Thyroid Disorders

Start date: June 25, 2022
Phase:
Study type: Observational

Fallopian tubes participate in the incorporation of gametes and embryos into the endometrial cavity. It also provides an optimal environment for flattening and early embryonic development. Tubal pathologies can cause both primary and secondary infertility. This condition has been associated with overt and subclinical hypothyroidism. However, the effects of hypothyroidism on tubal activity are not fully known. Although a few animal experiment studies on this subject have been published, there is no study on this subject in the literature. Demonstrating that epithelial and smooth muscle cells of rat fallopian tubes express thyroid receptors in animal experiments showed that fallopian tubes are targets for thyroid hormones. Again, in an animal experiment study, it was revealed that thyroid hormones have an important control on glycogen and lipid storage, lipid signaling and lymphocyte infiltration, which have an important role in maintaining the microenvironment in the rat fallopian tubes. This microenvironment is necessary for fertilization, sperm capacitation and gamete development. In another animal experimental study, it was thought that changes in the size of the epithelium of the fallopian tubes and cell metabolism in hypothyroid rabbits may affect oviductal activity and reproductive functions. An ectopic pregnancy is defined as a pregnancy implanted outside of the uterus. Ectopic pregnancy >98% implants in the fallopian tube. The etiology of ectopic pregnancy is unclear, but tubal implantation is probably due to impaired embryo-tubal transport. This is due to changes in the tubal environment. Based on this information, we aim to determine the possible relationship between hypothyroidism and ectopic pregnancy in humans in our study.

NCT ID: NCT05374720 Recruiting - Hysterectomy Clinical Trials

Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy

CILTUBE
Start date: October 1, 2022
Phase: N/A
Study type: Interventional

Primary Ciliary Dyskinesia associated with abnormalities of lateralization of organs (with existence of a situs inversus in 50% of cases) and secondary fertility disorders related in humans to abnormalities of mobility of sperm but very little data on the structure and function of tubal cilia in women

NCT ID: NCT05208034 Completed - Ectopic Pregnancy Clinical Trials

Medical Treatment in Ectopic Tubal Pregnancy

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

Ectopic pregnancy (EP) is estimated to be responsible for approximately 20% of all pregnancy-related mortality and 46% early pregnancy mortality.1 Hemodynamically stable women with EP are frequently managed with methotrexate (MTX) while multiple protocols like fixed multiple doses, single-dose as well as two-dose regimens have been in practice for treating EP, but no consensus exists regarding the optimum dosage regimen.

NCT ID: NCT05198141 Completed - Ectopic Pregnancy Clinical Trials

Evaluation of Different Doses of Letrozole in Ectopic Pregnancy

letrezole
Start date: December 15, 2020
Phase: Phase 4
Study type: Interventional

The utilization of letrozole at a daily dose of 10 mg for medical treatment of ectopic pregnancy considerably has a high success rate without imposing any serious side effects compared to daily 5mg letrozole.